Open an Account
search icon
1
NOTIFICATIONS
Best Algo trading app in India
Bigul

LINCOLN PHARMACEUTICALS LTD. - 531633 - Board Meeting Intimation for Consider And Approve Draft Scheme Of Amalgamation Of Lincoln Parenteral Limited ('The Transferor Company') With Lincoln Pharmaceuticals Limited ('The Transferee Company').

 LINCOLN PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/09/2019 ,inter alia, to consider and approve Draft scheme of amalgamation of Lincoln Parenteral Limited ('The Transferor Company') with Lincoln Pharmaceuticals Limited ('The Transferee Company') and Any other businesses with the permission of the Board.
10-09-2019
Bigul

LINCOLN PHARMACEUTICALS LTD. - 531633 - Submission Of Newspaper Copies Of Annual General Meeting Notice.

 Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the notice published in Newspapers on September 06, 2019 informing members of the Company regarding conveying Annual General Meeting on Monday, September 30, 2019 at 10:30 a.m. at the Registered Office of the Company and Remote E-Voting facility offered to the members.
06-09-2019
Bigul

LINCOLN PHARMACEUTICALS LTD. - 531633 - Fixes Book Closure For Dividend And Annual General Meeting

 Lincoln Pharmaceuticals Ltd has informed that the Register of Members & Share Transfer Books of the Company will remain closed from September 21, 2019 to September 30, 2019 (both days inclusive) for the purpose of Payment of Dividend and Annual General Meeting of the Company, scheduled to be held on September 30, 2019.
05-09-2019
Bigul

Lincoln Pharmaceuticals Ltd - 531633 - Reg. 34 (1) Annual Report

 Pursuant to Regulation 34 (1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Annual Report for the financial year 2018-19 of the Company along with Notice of the twenty fifth Annual General Meeting of the Company scheduled to be held on Monday, September 30, 2019 at 10.30 a.m.
05-09-2019
Bigul

Lincoln Pharmaceuticals Ltd - 531633 - Twenty Fifth Annual General Meeting Scheduled To Be Held On Monday, September 30, 2019.

 We are submitting herewith the Annual Report of the Company for the financial year 2018-2019 along with Notice of the Twenty Fifth Annual General Meeting of the Company scheduled to be held on Monday, September 30, 2019 at the Registered office of the Company at 10.30 a.m.
05-09-2019
Bigul

Lincoln Pharmaceuticals Ltd - 531633 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the copies of Notice Published in the Newspapers dated September 04, 2019, regarding notice sent to the Shareholders for transfer of all shares in respect of which dividend has not been paid or claimed by the them for seven consecutive years or more to the Investor Education and Protection Fund (IEPF) Authority, in accordance with the provision of Section 124 (6) of the Companies Act, 2013 read with Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016 and amendment made thereon on time to time.
04-09-2019
Bigul

Lincoln Pharmaceuticals Ltd - 531633 - Financial Result For The Quarter Ended June 30, 2019

 we would like to inform that the Board of Directors of the Company at their meeting held today, i.e. on August 14, 2019 had considered following: 1.To Considered and Approved Standalone and Consolidated Un-Audited Financial Results for the Quarter Ended on June 30, 2019. 2.The Limited Review Report on Standalone and Consolidated Un-Audited Financial Results received from Statutory Auditors for the aforesaid Quarter.
14-08-2019
Bigul

Lincoln Pharmaceuticals Ltd - 531633 - Outcome of Board Meeting

 we would like to inform that the Board of Directors of the Company at their meeting held today, i.e. on August 14, 2019 had considered following: 1.To Considered and Approved Standalone and Consolidated Un-Audited Financial Results for the Quarter Ended on June 30, 2019. 2.The Limited Review Report on Standalone and Consolidated Un-Audited Financial Results received from Statutory Auditors for the aforesaid Quarter.
14-08-2019
Bigul

Lincoln Pharmaceuticals Ltd - 531633 - Board Meeting Intimation for Inter-Alia To Consider And Approve The Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended On June 30, 2019

 LINCOLN PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2019 ,inter alia, to consider and approve the Meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, August 14, 2019 at the Registered Office of the Company inter-alia to consider and approve the Un-Audited Standalone and Consolidated Financial Results of the Company for the Quarter Ended on June 30, 2019 along with any other business, if any. Further, in continuation to our disclosure on Closure of Trading Window dated June 28, 2019, pursuant to the provisions of the SEBI (PIT) Regulations, 2015 and the Company''s Code of Conduct for Prevention of Insider Trading, it may be noted that the trading window has been closed for Designated Persons viz Directors, identified Employees, KMPs, Promoter and Promoter Group of the Company and its subsidiaries including Immediate Relatives of the Designated Persons of the Company and its subsidiaries and for the Connected Persons from June 29, 2019 and shall reopen after the expiry of 48 hours from the time the result becomes generally available.
03-08-2019
Bigul

LINCOLN PHARMACEUTICALS LTD. - 531633 - Shareholding for the Period Ended June 30, 2019

 Lincoln Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click here
19-07-2019
Next Page
Close

Let's Open Free Demat Account